Barbituric Acid

Barbituric Acid

SCHEMBL1470199

O=C1CC(=O)NC(=O)N1.OO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP1A2 P05177 1/20 0.50
HPGD P15428 1/20 0.50
HIF1A Q16665 1/20 0.50
ITGB3 P05106 1/20 0.46
ITGB1 P05556 1/20 0.46
ITGAV P06756 1/20 0.46
ITGA4 P13612 1/20 0.46
CRBN Q96SW2 4/20 0.39
KDM4E B2RXH2 1/20 0.35
OGT O15294 1/20 0.35
USP2 O75604 1/20 0.35
MAPT P10636 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
SRC P12931 1/20 0.34
AHR P35869 1/20 0.33
PDK2 Q15119 1/20 0.33
TDP2 O95551 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Barbituric Acid SCHEMBL38707 0.93
Barbituric Acid SCHEMBL9941322 0.93
Barbituric Acid SCHEMBL4560317 0.93 ALDH1A1 (0.55) HSD17B10ALDH1A1CYP1A2HPGDHIF1A
Barbituric Acid SCHEMBL28610609 0.90 ALDH1A1 (0.52) HSD17B10ALDH1A1CYP1A2HPGDHIF1A
Barbituric Acid SCHEMBL28362335 0.90 ALDH1A1 (0.52) HSD17B10ALDH1A1CYP1A2HPGDHIF1A
Barbituric Acid SCHEMBL11379882 0.90 ALDH1A1 (0.52) HSD17B10ALDH1A1CYP1A2HPGDHIF1A
Barbituric Acid SCHEMBL28943815 0.90 ALDH1A1 (0.52) HSD17B10ALDH1A1CYP1A2HPGDHIF1A
Barbituric Acid SCHEMBL1974368 0.90 ALDH1A1 (0.52) HSD17B10ALDH1A1CYP1A2HPGDHIF1A
Barbituric Acid SCHEMBL1973830 0.90 ALDH1A1 (0.52) HSD17B10ALDH1A1CYP1A2HPGDHIF1A
Barbituric Acid SCHEMBL5924412 0.90 ALDH1A1 (0.52) HSD17B10ALDH1A1CYP1A2HPGDHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9381140-B2 Radically polymerisable dental material, cured product and usage KETTENBACH GMBH & CO. KG (DE) 2016-07-05 US disclosed
US-20150231041-A1 Radically Polymerisable Dental Material, Cured Product and Usage KETTENBACH GMBH & CO. KG (DE) 2015-08-20 US disclosed
EP-1765261-B1 DENTAL COMPOSITION CONTAINING UNSATURATED CARBOSILANE CONTAINING COMPONENTS MINNESOTA MINING MFG GMBH (DE) 2015-08-19 EP disclosed
US-8551149-B2 Corrective method for fingernails or toenails HILLEBRAND CHRISTA (DE) 2013-10-08 US disclosed
US-20120191033-A1 CORRECTIVE METHOD FOR FINGERNAILS OR TOENAILS HILLEBRAND CHRISTA (DE) 2012-07-26 US disclosed
CN-1988875-B Dental compositions containing unsaturated carbosilane containing components 3M ESPE AG 2012-05-02 CN disclosed
US-7915324-B2 Curable di- or polyunsaturated carbosilane containing silicon-aryl bondand no silicon-oxygen bonds; initiator, filler, dyes, pigments, thixotropic agents, flow control agents, polymeric thickeners, surfactants, odorous substances, diluting agent(s) and flavors; crowns, bridges 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-03-29 US disclosed
US-20070207443-A1 Dental composition containing unsaturated carbosilane containing components 3M INNOVATIVE PROPERTIES COMPANY 2007-09-06 US disclosed
CN-1988875-A Dental compositions containing unsaturated carbosilane containing components 3M ESPE AG (DE) 2007-06-27 CN disclosed
EP-1765261-A1 DENTAL COMPOSITION CONTAINING UNSATURATED CARBOSILANE CONTAINING COMPONENTS 3M Espe AG (DE) 2007-03-28 EP disclosed
US-6566413-B1 For dental and dental engineering applications 3M ESPE AG (DE) 2003-05-20 US disclosed
CN-1368872-A Adhesive systems 3M ESPE DENTAL AG (DE) 2002-09-11 CN disclosed
US-6245872-B1 APPLYING TO HARD TOOTH SUBSTANCE UNPOLYMERIZED MIXTURE OF SINGLY OR REPEATEDLY ETHYLENICALLY UNSATURATED PHOSPHORIC ACID ESTER, SOLVENT, INITIATOR WHICH CAN FORM FREE RADICALS; COATING APPLIED MIXTURE WITH POLYMERIZABLE FILLING MATERIAL ESPE DENTAL AG (DE) 2001-06-12 US disclosed
US-6147136-A CURING; FREE RADICAL OR CATIONIC POLYMERIZATION; CEMENTING ESPE DENTAL AG (DE) 2000-11-14 US disclosed
US-6075068-A RAPID POLYMERIZATION PROCESS, LEADING TO PARTIALLY OR FULLY CURED MATERIALS WHICH EXHIBIT LITTLE VOLUME SHRINKAGE, LITTLE ABRASION TENDENCY AND GOOD MECHANICAL PROPERTIES ESPE DENTAL AG (DE) 2000-06-13 US disclosed
US-6034152-A DENTAL COMPOSITE CONTAINING ACRYLATE THERA PATENT GMBH & CO. KG (DE) 2000-03-07 US disclosed
US-5244933-A DENTAL COMPOSITIONS WHICH CAN BE PREPARED AND WORKED BY THE ACTION OF OSCILLATIONS AND METHOD FOR THE PREPARATION THEREOF THERA PATENT GMBH & CO. KG GESELLSCHAFT FUR INDUSTRIELLE SCHUTZRECHTE (DE) 1993-09-14 US disclosed
US-4906446-A Filler for dental materials and dental materials containing the same BARD AUTOTRANSFUSION ACQUISITION CORPORATION 1990-03-06 US disclosed
US-4882365-A Polymerizable radiopaque dental composition ESPE STIFTUNG & CO. PRODUKTIONS- UND VERTRIEBS KG (DE) 1989-11-21 US disclosed
US-4767798-A YTTRIUM FLUORIDE OR ALKALINE EARTH HEXAFLUORO-ZIRCONATE, -TITANATE OR -HAFNATE ESPE STIFTUNG & CO. PRODUKTIONS- UND VERTRIEBS KG (DE) 1988-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070207443-A1 Dental composition containing unsaturated carbosilane containing components TAS1R1, TAS2R41, TAS2R39 HSD17B10 3173/4885ALDH1A1 1136/4885CYP1A2 3705/4885
US-20150231041-A1 Radically Polymerisable Dental Material, Cured Product and Usage MMAB, MTCL3, TUBB4B HSD17B10 2606/4885ALDH1A1 1519/4885CYP1A2 1999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.